inflammatory bowel disease

Although it has seemingly tried to do everything, everywhere, all at once with its immune sequencing technology, Adaptive has sharpened its focus. 

The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO.

The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics.